Navigation Links
Kenyan Minister of Medical Services Officially Opens Kitale Eye Unit
Date:10/2/2010

Kenyan Minister of Medical Services Officially Opens Kitale Eye Unit -- TORONTO, October 1, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, New Products & Services Click to view news release full screen  

Kenyan Minister of Medical Services Officially Opens Kitale Eye Unit

 

TORONTO, October 1, 2010 /PRNewswire/ -- Hon. Prof. Anyang' Nyong'o, Minister of Medical Services, officially declared the Eye Unit of the Kitale District Hospital open before a crowd of dignitaries, local residents and school children. The Eye Unit was built by Operation Eyesight Universal, an international development organization based in Canada.

"It's all about building local capacity," says Pat Ferguson, Operation Eyesight Universal's President and CEO. "This grand opening of the eye clinic at the Kitale District Hospital is another step in the development of quality, sustainable eye care services."

Since 2002, the generous Canadian donors at Operation Eyesight have invested almost $3.5 million US or 276 million Schillings in Kenya for construction and/or refurbishment of eye clinics and operating theatres in Narok, Kitale, Kapsabet and Kapenguria. Operation Eyesight has also supported hospital operating costs and the Narok Trachoma Project.

"We are proud to work with the Government of Kenya to focus our efforts and investments on development projects that will demonstrate effective models of sustainable services in primary and secondary eye care, as well as community projects that attack and eliminate the root causes of blindness," stated Ferguson.

Operation Eyesight is an international development organization dedicated to preventing and treating avoidable blindness in low income countries for almost 50 years-primarily in India and Africa. We help local medical professionals provide blindness prevention programs and comprehensive, sustainable eye care for the people of the world who can least afford it. Since 1963, Operation Eyesight has prevented blindness in more than 35 million people. For more information, visit http://www.operationeyesight.com.

Global Blindness: Every five seconds, one person in our world goes blind and a child goes blind every minute. More than 90 per cent of the world's blind live in developing countries, where day-to-day life is already daunting and blindness is a direct threat to life. Over 80 per cent of this blindness is preventable or treatable.

Trachoma is a disease of the eye caused by bacterial infection and is easily spread. Children are most susceptible. The disease progresses gradually until scarring from prolonged infection causes the eyelashes to turn inward and scratch the cornea, leading slowly and painfully to complete blindness. In the developing world, more than 80 million people are affected by trachoma with over 8 million suffering the late painful stage of the disease.

Sanitation: More than 1.2 billion people in the world do not have even the most basic sanitation facilities.

Clean Water: More than 884 million people in the world do not have access to clean water.

For further information: For interviews, photos or more information, please contact: Lindsay O'Connor, Head of International Media Operation Eyesight Universal, Phone: +1-416-438-7280, Mobile: +1-647-404-4469, Toll-free: +1-800-585-8265, Fax: +1-416-438-6132, oconnor@operationeyesight.com, http://www.operationeyesight.com, OPERATION EYESIGHT UNIVERSAL, Suite 208, 2100 Ellesmere Road, Toronto, Ontario, Canada, M1H 3B7


'/>"/>
SOURCE Operation Eyesight Universal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
2. Zydus Novel Orally Administered GLP-1 Agonist - ZYOG1 to treat Diabetes and Obesity Enters Phase I Clinical Trial
3. Study Data Show INTUNIV™ (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
4. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
5. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
6. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
7. Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
8. Genasense(R) Can be Administered by Brief High-Dose IV Infusion
9. Clayton, Dubilier & Rice and GS Capital Partners Complete Acquisition of Medical Supplies Distributor
10. Experts Say Medicares Bidding System for Medical Equipment Will Fail
11. Reportlinker Adds Global Medical Plastics Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to ... and other developmental disabilities. The group, which is being launched with the help of ... to share stories and advice, seek help, and continue their education on how to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. ... will be included in the 2016 “Guide to America’s Top Plastic Surgeons” for ... the amalgamation of their education, experience, and professional associations. , One the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... announce that we have been designated as a Cigna Infertility Center of Excellence. ... rigorous performance standards. , “It’s an honor to be designated a Cigna ...
Breaking Medicine News(10 mins):